BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7448778)

  • 21. Hypoxic cell specific chemotherapeutic agents.
    Sartorelli AC
    Adv Enzyme Regul; 1982; 20():233-44. PubMed ID: 6810658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement by hyperthermia of the in vitro cytotoxicity of mitomycin C toward hypoxic tumor cells.
    Teicher BA; Kowal CD; Kennedy KA; Sartorelli AC
    Cancer Res; 1981 Mar; 41(3):1096-9. PubMed ID: 7459853
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypoxia-selective antitumor agents. 14. Synthesis and hypoxic cell cytotoxicity of regioisomers of the hypoxia-selective cytotoxin 5-[N,N-bis(2-chloroethyl)amino]-2,4-dinitrobenzamide.
    Palmer BD; Wilson WR; Anderson RF; Boyd M; Denny WA
    J Med Chem; 1996 Jun; 39(13):2518-28. PubMed ID: 8691449
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adducts of mitomycin C and DNA in EMT6 mouse mammary tumor cells: effects of hypoxia and dicumarol on adduct patterns.
    Bizanek R; Chowdary D; Arai H; Kasai M; Hughes CS; Sartorelli AC; Rockwell S; Tomasz M
    Cancer Res; 1993 Nov; 53(21):5127-34. PubMed ID: 7693331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response of aerobic and hypoxic cells in a solid tumor to adriamycin and cyclophosphamide and interaction of the drugs with radiation.
    Tannock I
    Cancer Res; 1982 Dec; 42(12):4921-6. PubMed ID: 7139596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of hypoxia in anticancer drug-induced cytotoxicity for Ehrlich ascites cells.
    Gupta V; Costanzi JJ
    Cancer Res; 1987 May; 47(9):2407-12. PubMed ID: 2436764
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
    Mulcahy RT; Dembs N
    Cancer Res; 1983 Aug; 43(8):3539-43. PubMed ID: 6861127
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytotoxicity and DNA crosslinks produced by mitomycin analogs in aerobic and hypoxic EMT6 cells.
    Keyes SR; Loomis R; DiGiovanna MP; Pritsos CA; Rockwell S; Sartorelli AC
    Cancer Commun; 1991; 3(10-11):351-6. PubMed ID: 1760250
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of deficiencies in DNA repair on the toxicity of mitomycin C and porfiromycin to CHO cells under aerobic and hypoxic conditions.
    Hughes CS; Irvin CG; Rockwell S
    Cancer Commun; 1991 Feb; 3(2):29-35. PubMed ID: 1899798
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancement of mitomycin C cytotoxicity to hypoxic tumor cells by dicoumarol in vivo and in vitro.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1985 Jan; 45(1):213-6. PubMed ID: 2578093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
    Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activity of mitomycin C for aerobic and hypoxic cells in vitro and in vivo.
    Rauth AM; Mohindra JK; Tannock IF
    Cancer Res; 1983 Sep; 43(9):4154-8. PubMed ID: 6409398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential killing efficacy of twenty antitumor drugs on proliferating and nonproliferating human tumor cells.
    Drewinko B; Patchen M; Yang LY; Barlogie B
    Cancer Res; 1981 Jun; 41(6):2328-33. PubMed ID: 7237431
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation between drug uptake and selective toxicity of porfiromycin to hypoxic EMT6 cells.
    Keyes SR; Rockwell S; Sartorelli AC
    Cancer Res; 1987 Nov; 47(21):5654-7. PubMed ID: 3664473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Failure of 5-thio-D-glucose to alter cell survival in irradiated or unirradiated EMT6 tumors.
    Rockwell S; Schulz RJ
    Radiat Res; 1984 Dec; 100(3):527-35. PubMed ID: 6505142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytotoxicity, radiosensitization, and DNA interaction of platinum complexes of thiazin and xanthene dyes.
    Teicher BA; Herman TS; Kaufmann ME
    Radiat Res; 1990 Feb; 121(2):187-95. PubMed ID: 2305037
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of mitomycin C and porfiromycin on exponentially growing and plateau phase cultures.
    Rockwell S; Hughes CS
    Cell Prolif; 1994 Mar; 27(3):153-63. PubMed ID: 10465006
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The problems of combining chemotherapy and radiotherapy].
    Tanaka Y; Hasegawa T; Akagi K; Kato T
    Gan No Rinsho; 1987 Oct; 33(13):1664-72. PubMed ID: 3694800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cancer chemotherapy on the hypoxic fraction of a solid tumor measured using a local tumor control assay.
    Grau C; Overgaard J
    Radiother Oncol; 1988 Dec; 13(4):301-9. PubMed ID: 2464183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.